Citizens Stock Forecast, Price & News

Citizens (NYSE:CIA) Frequently Asked Questions

Is Citizens a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Citizens in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Citizens stock.
View analyst ratings for Citizens or view top-rated stocks.

What stocks does MarketBeat like better than Citizens?

Wall Street analysts have given Citizens a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Citizens wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Citizens' next earnings date?

Citizens is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Citizens.

How were Citizens' earnings last quarter?

Citizens, Inc. (NYSE:CIA) announced its earnings results on Thursday, August, 5th. The insurance provider reported $0.10 earnings per share for the quarter. The insurance provider earned $58.70 million during the quarter. Citizens had a positive trailing twelve-month return on equity of 1.60% and a negative net margin of 2.02%.
View Citizens' earnings history.

How has Citizens' stock price been impacted by Coronavirus (COVID-19)?

Citizens' stock was trading at $4.57 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CIA stock has increased by 34.1% and is now trading at $6.13.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CIA?

2 analysts have issued 12-month target prices for Citizens' shares. Their forecasts range from $4.00 to $8.40. On average, they expect Citizens' stock price to reach $6.20 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price.
View analysts' price targets for Citizens or view top-rated stocks among Wall Street analysts.

Who are Citizens' key executives?

Citizens' management team includes the following people:

• Gerald W. Shields, Vice Chairman, President & Chief Executive Officer
• Jeffery P. Conklin, Chief Financial Officer, Treasurer & VP
• Chad Mellon, Chief Information Officer & Vice President
• Robert M. Mauldin, Chief Marketing Officer & Vice President
• Harvey Waite, Chief Actuary Officer & Vice President

What is Geoffrey M. Kolander's approval rating as Citizens' CEO?

11 employees have rated Citizens CEO Geoffrey M. Kolander on Glassdoor.com. Geoffrey M. Kolander has an approval rating of 83% among Citizens' employees.

Who are some of Citizens' key competitors?

Some companies that are related to Citizens include MetLife (MET), Prudential Financial (PRU), Aflac (AFL), Lincoln National (LNC), Primerica (PRI), Unum Group (UNM), CNO Financial Group (CNO), American Equity Investment Life (AEL), National Western Life Group (NWLI), Independence (IHC) and Kansas City Life Insurance (KCLI).
View all of CIA's competitors.

What other stocks do shareholders of Citizens own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Citizens investors own include Corcept Therapeutics (CORT), Fate Therapeutics (FATE), Huntington Bancshares (HBAN), KeyCorp (KEY), People's United Financial (PBCT), (PRMW), AT&T (T), The AES (AES), AK Steel (AKS) and Advanced Micro Devices (AMD).

What is Citizens' stock symbol?

Citizens trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIA."

Who are Citizens' major shareholders?

Citizens' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.01%), Vanguard Group Inc. (4.63%), Dimensional Fund Advisors LP (2.30%), State Street Corp (1.87%), Geode Capital Management LLC (1.56%) and Northern Trust Corp (0.95%).
View institutional ownership trends for Citizens.

Which institutional investors are selling Citizens stock?

CIA stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Dimensional Fund Advisors LP, JPMorgan Chase & Co., California Public Employees Retirement System, Vanguard Group Inc., Northern Trust Corp, Bank of America Corp DE, and Renaissance Technologies LLC.
View insider buying and selling activity for Citizens or view top insider-selling stocks.

Which institutional investors are buying Citizens stock?

CIA stock was purchased by a variety of institutional investors in the last quarter, including Parametric Portfolio Associates LLC, Geode Capital Management LLC, Bridgeway Capital Management LLC, Balyasny Asset Management LLC, Morgan Stanley, Morgan Stanley, Russell Investments Group Ltd., and Squarepoint Ops LLC.
View insider buying and selling activity for Citizens or or view top insider-buying stocks.

How do I buy shares of Citizens?

Shares of CIA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Citizens' stock price today?

One share of CIA stock can currently be purchased for approximately $6.13.

How much money does Citizens make?

Citizens has a market capitalization of $304.23 million and generates $238.86 million in revenue each year.

How many employees does Citizens have?

Citizens employs 245 workers across the globe.

What is Citizens' official website?

The official website for Citizens is www.citizensinc.com.

Where are Citizens' headquarters?

Citizens is headquartered at 14231 TANDEM BOLIVERD 2ND FLOOR, AUSTIN TX, 78714.

How can I contact Citizens?

Citizens' mailing address is 14231 TANDEM BOLIVERD 2ND FLOOR, AUSTIN TX, 78714. The insurance provider can be reached via phone at (512) 837-7100 or via email at investor relations [email protected].